Matches in SemOpenAlex for { <https://semopenalex.org/work/W3094017653> ?p ?o ?g. }
- W3094017653 endingPage "096368972094849" @default.
- W3094017653 startingPage "096368972094849" @default.
- W3094017653 abstract "Bisphosphonates (BPs) are widely used to treat several metabolic and oncological diseases affecting the skeletal system. Despite BPs’ well-known therapeutic potential, they also displayed important side effects, among which is BPs-related osteonecrosis of the jaw, by targeting osteoclast activities, osteoblast, and osteocyte behavior. The aim of this study is to evaluate the biological effects of zoledronic acid (ZOL) in an in vitro model of periodontal ligament stem cells (PDLSCs) by using an experimental setting that resembles the in vivo conditions. PDLSCs were treated with different concentrations of ZOL ranging from 0.1 to 5 μM. The effects of ZOL exposure were evaluated on cell viability via 3-[4,5-Dimethylthiaoly]-2,5-diphenyltetrazolium bromide (MTT), cell cycle analysis, apoptosis detection, and immunofluorescence. Quantitative real-time polymerase chain reaction (PCR), colorimetric detection of alkaline phosphatase activity, and Alizarin Red S staining were performed to investigate the osteogenic potential of PDLSCs exposed to ZOL. MTT analysis showed that the viability of PDLSCs exposed to ZOL concentration ≥1.5 μM for 3 and 6 days was significantly lower ( P < 0.001) than that of untreated cells. The percentage of apoptotic cells was significantly higher in PDLSCs exposed for 4 days to ZOL at 2 μM ( P < 0.01) and 5 μM ( P < 0.001) when compared to the control. Moreover, ZOL treatment (3 days) accounted for alterations in cell cycle distribution, with an increase in the proportion of cells in G0/G1 phase and a reduction in the proportion of cells in S phase. Chronic exposure (longer than 7 days) of PDLSCs to ZOL accounted for the downregulation of ALP, RUNX2, and COL1 genes at all tested concentrations, which fit well with the reduced alkaline phosphatase activity reported after 7 and 14 days of treatment. Reduced Col1 deposition in the extracellular matrix was reported after 14 days of treatment. Increased calcium deposits were observed in treated cells when compared to the control cultures. In conclusion, chronic exposure to 1 μM ZOL induced significant reduction of osteogenic differentiation, while ZOL concentrations ≥1.5 μM are required to impair PDLSCs viability and induce apoptosis." @default.
- W3094017653 created "2020-10-29" @default.
- W3094017653 creator A5003216897 @default.
- W3094017653 creator A5032470839 @default.
- W3094017653 creator A5038227158 @default.
- W3094017653 creator A5050653274 @default.
- W3094017653 creator A5054057326 @default.
- W3094017653 creator A5064584328 @default.
- W3094017653 creator A5069061336 @default.
- W3094017653 creator A5069404608 @default.
- W3094017653 creator A5083989294 @default.
- W3094017653 date "2020-01-01" @default.
- W3094017653 modified "2023-10-05" @default.
- W3094017653 title "Dose-Dependent Effects of Zoledronic Acid on Human Periodontal Ligament Stem Cells: An <i>In Vitro</i> Pilot Study" @default.
- W3094017653 cites W1526267197 @default.
- W3094017653 cites W1969939915 @default.
- W3094017653 cites W1971021106 @default.
- W3094017653 cites W1972567449 @default.
- W3094017653 cites W1982991732 @default.
- W3094017653 cites W1996327205 @default.
- W3094017653 cites W1998464304 @default.
- W3094017653 cites W1999024824 @default.
- W3094017653 cites W2003692790 @default.
- W3094017653 cites W2004904260 @default.
- W3094017653 cites W2012426941 @default.
- W3094017653 cites W2018516726 @default.
- W3094017653 cites W2028333787 @default.
- W3094017653 cites W2037723165 @default.
- W3094017653 cites W2061794205 @default.
- W3094017653 cites W2069095331 @default.
- W3094017653 cites W2070381129 @default.
- W3094017653 cites W2076769374 @default.
- W3094017653 cites W2076831756 @default.
- W3094017653 cites W2085816677 @default.
- W3094017653 cites W2087065120 @default.
- W3094017653 cites W2087908455 @default.
- W3094017653 cites W2093531170 @default.
- W3094017653 cites W2104075031 @default.
- W3094017653 cites W2107208293 @default.
- W3094017653 cites W2116154813 @default.
- W3094017653 cites W2127028445 @default.
- W3094017653 cites W2128956996 @default.
- W3094017653 cites W2134304734 @default.
- W3094017653 cites W2140077889 @default.
- W3094017653 cites W2142670098 @default.
- W3094017653 cites W2144224215 @default.
- W3094017653 cites W2154304147 @default.
- W3094017653 cites W2170955783 @default.
- W3094017653 cites W2178101041 @default.
- W3094017653 cites W2559774788 @default.
- W3094017653 cites W2591659741 @default.
- W3094017653 cites W2769325014 @default.
- W3094017653 cites W2777672318 @default.
- W3094017653 cites W2782861663 @default.
- W3094017653 cites W2791031405 @default.
- W3094017653 cites W2792604432 @default.
- W3094017653 cites W2810262144 @default.
- W3094017653 cites W2898989386 @default.
- W3094017653 cites W2903619415 @default.
- W3094017653 cites W2905174710 @default.
- W3094017653 cites W2931103975 @default.
- W3094017653 cites W2947176123 @default.
- W3094017653 cites W3003485315 @default.
- W3094017653 doi "https://doi.org/10.1177/0963689720948497" @default.
- W3094017653 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7784504" @default.
- W3094017653 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33086890" @default.
- W3094017653 hasPublicationYear "2020" @default.
- W3094017653 type Work @default.
- W3094017653 sameAs 3094017653 @default.
- W3094017653 citedByCount "42" @default.
- W3094017653 countsByYear W30940176532020 @default.
- W3094017653 countsByYear W30940176532021 @default.
- W3094017653 countsByYear W30940176532022 @default.
- W3094017653 countsByYear W30940176532023 @default.
- W3094017653 crossrefType "journal-article" @default.
- W3094017653 hasAuthorship W3094017653A5003216897 @default.
- W3094017653 hasAuthorship W3094017653A5032470839 @default.
- W3094017653 hasAuthorship W3094017653A5038227158 @default.
- W3094017653 hasAuthorship W3094017653A5050653274 @default.
- W3094017653 hasAuthorship W3094017653A5054057326 @default.
- W3094017653 hasAuthorship W3094017653A5064584328 @default.
- W3094017653 hasAuthorship W3094017653A5069061336 @default.
- W3094017653 hasAuthorship W3094017653A5069404608 @default.
- W3094017653 hasAuthorship W3094017653A5083989294 @default.
- W3094017653 hasBestOaLocation W30940176531 @default.
- W3094017653 hasConcept C126322002 @default.
- W3094017653 hasConcept C150903083 @default.
- W3094017653 hasConcept C160160445 @default.
- W3094017653 hasConcept C16685009 @default.
- W3094017653 hasConcept C181199279 @default.
- W3094017653 hasConcept C185592680 @default.
- W3094017653 hasConcept C190283241 @default.
- W3094017653 hasConcept C202751555 @default.
- W3094017653 hasConcept C207001950 @default.
- W3094017653 hasConcept C2776326535 @default.
- W3094017653 hasConcept C2778260815 @default.
- W3094017653 hasConcept C2779886569 @default.
- W3094017653 hasConcept C2780783641 @default.